The ATEV™ was observed to have superior duration of use over 24 months compared to autogenous fistula in high-need subgroups with historically poor outcomes with AV fistula procedures – – The ...

Anal fistulas affect about 2 in 10,000 people yearly, with a higher prevalence in young men. Most fistulas form due to blocked anal glands, resulting in infection and abscess formation. Fistulas are ...

Humacyte (HUMA) announced the presentation of positive two-year results from the V007 Phase 3 clinical trial of the acellular tissue engineered ...

PHOENIX -- An implantable autologous cell therapy led to higher remission rates compared with standard surgical care in ...

Andrew J. Stillman is a freelance writer and yoga instructor exploring the world. Check him out at andrewjstillman.com or follow him @andrewjstillman on all the things.

When Faisa Idow went into labour with her first child, she sensed something was terribly wrong. The 23-year-old from a rural ...

Speakers at this year’s Maltiti Care International Maternal Health Summit have said that limited access to specialist ...

Sharon Korir. Her experience with Obstetric fistula was physically and mentally challenging. [File, Standard] Obstetric fistula is one of the most tormenting conditions that women undergo not only in ...

Venova Medical Announces First Subjects Enrolled in VENOS-3 Pivotal IDE Study of the Velocity (R) Percutaneous AVF System The Velocity System is a next generation percutaneous AVF technology designed ...

Venova Medical announced the enrollment of the first patients in the VENOS-3 pivotal study of the company’s Velocity perc ...

The target lesion primary patency (TLPP)1 and access circuit primary patency (ACPP)2 of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE) ...